Both PrP and CML exhibited much lower abundance in the thalamic regions of control brains compared to infected brains, indicating few or no PrP and CML deposits in control brains (Fig. 1). This evidence concerns the gene PRNP and chronic myelogenous leukemia, BCR-ABL1 positive.